Serum autotaxin is a parameter for the severity of liver cirrhosis and overall survival in patients with liver cirrhosis - A prospective cohort study

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Pleli, Thomas ^a   Martin, Daniel ^a   Kronenberger, Bernd ^a   Brunner, Friederike ^a   Köberle, Verena ^a   Grammatikos, Georgios ^a   Farnik, Harald ^a   Martinez, Yolanda ^a   Finkelmeier, Fabian ^a   Labocha, Sandra ^a   Ferreirós, Nerea ^a   Zeuzem, Stefan ^a   Piiper, Albrecht ^a   Waidmann, Oliver ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOTAXIN; LYSOPHOSPHATIDIC ACID; ALKYLGLYCEROPHOSPHOETHANOLAMINE PHOSPHODIESTERASE; BIOLOGICAL MARKER; PHOSPHODIESTERASE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CHILD PUGH SCORE; COHORT ANALYSIS; CONTROLLED STUDY; DECOMPENSATED LIVER CIRRHOSIS; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS VARICES; FEMALE; GOLD STANDARD; HEPATIC ENCEPHALOPATHY; HUMAN; LIQUID CHROMATOGRAPHY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; OVERALL SURVIVAL; PHOSPHOLIPID BLOOD LEVEL; PORTAL HYPERTENSION; PREDICTIVE VALUE; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; BLOOD; CLINICAL TRIAL; MIDDLE AGED; SURVIVAL;

ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PHOSPHORIC DIESTER HYDROLASES; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84904899990     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103532     Document Type: Article

References (34)

1. Wallace K, Burt AD, Wright MC (2008) Liver fibrosis. Biochem J 2008; 411: 1-18. (Pubitemid 351482341)
2. Cárdenas A, Ginès P (2011) Management of patients with cirrhosis awaiting liver transplantation. Gut 60:412-421.
3. Nouchi T, Tanaka Y, Tsukada T, Sato C, Marumo F (1991) Appearance of alpha-smooth-muscle-actin-positive cells in hepatic fibrosis. Liver 11:100-105.
4. Rockey DC, Boyles JK, Gabbiani G, Friedman SL (1992) Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J Submicrosc Cytol Pathol 24:193-203.
5. Yamaoka K, Nouchi T, Marumo F, Satoc C (1993) Alpha-smooth-muscle actin expression in normal and fibrotic human livers. Dig Dis Sci 38:1473-1479. (Pubitemid 23266628)
6. Tokumura A, Majima E, Kariya Y, Tominaga K, Kogure K, et al. (2002) Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J Biol Chem 277:39436-39442. (Pubitemid 35190918)
7. Umezu-Goto M, Kishi Y, Taira A, Hama K, Dohmae N, et al. (2002) Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol 158:227-233.
8. Ikeda H, Yatomi Y, Yanase M, Satoh H, Nishihara A, et al. (1998) Effects of lysophosphatidic acid on proliferation of stellate cells and hepatocytes in culture. Biochem Biophys Res Commun 248:436-440. (Pubitemid 28386442)
9. Yanase M, Ikeda H, Matsui A, Maekawa H, Noiri E, et al. (2000) Lysophosphatidic acid enhances collagen gel contraction by hepatic stellate cells: association with rho-kinase. Biochem Biophys Res Commun 277:72-78.
10. Ikeda H, Nagashima K, Yanase M, Tomiya T, Arai M, et al. (2003) Involvement of Rho/Rho kinase pathway in regulation of apoptosis in rat hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 285:G880-G886. (Pubitemid 37310067)
11. Jansen S, Stefan C, Creemers JW, Waelkens E, Van Eynde A, et al. (2005) Proteolytic maturation and activation of autotaxin (NPP2), a secreted metastasis-enhancing lysophospholipase D. J Cell Sci 118:3081-3089. (Pubitemid 41149912)
12. Iwasawa Y, Fujii T, Nagamatsu T, Kawana K, Okudaira S, et al. (2009) Expression of autotaxin, an ectoenzyme that produces lysophosphatidic acid, in human placenta. Am J Reprod Immunol 62:90-95.
13. Fotopoulou S, Oikonomou N, Grigorieva E, Nikitopoulou I, Paparountas T, et al. (2010) ATX expression and LPA signalling are vital for the development of the nervous system. Dev Biol 339:451-464.
14. Nakasaki T, Tanaka T, Okudaira S, Hirosawa M, Umemoto E, et al. (2008) Involvement of the lysophosphatidic acid-generating enzyme autotaxin in lymphocyte-endothelial cell interactions. Am J Pathol 173:1566-1576.
15. Tanaka M, Okudaira S, Kishi Y, Ohkawa R, Iseki S, et al. (2006) Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid. J Biol Chem 281:25822-25830. (Pubitemid 44401970)
16. van Meeteren LA, Ruurs P, Stortelers C, Bouwman P, van Rooijen MA, et al. (2006) Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development. Mol Cell Biol 26:5015-22. (Pubitemid 43955815)
17. Watanabe N, Ikeda H, Nakamura K, Ohkawa R, Kume Y, et al. (2007) Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C. J Clin Gastroenterol 41:616-623. (Pubitemid 46956520)
18. Nakagawa H, Ikeda H, Nakamura K, Ohkawa R, Masuzaki R, et al. (2011) Autotaxin as a novel serum marker of liver fibrosis. Clin Chim Acta 412:1201-1206.
19. Masuda A, Nakamura K, Izutsu K, Igarashi K, Ohkawa R, et al. (2008) Serum autotaxin measurement in haematological malignancies: a promising marker for follicular lymphoma. Br J Haematol 143:60-70.
20. Nakai Y, Ikeda H, Nakamura K, Kume Y, Fujishiro M, et al. (2011) Specific increase in serum autotaxin activity in patients with pancreatic cancer. Clin Biochem 44:576-581.
21. Zhang G, Zhao Z, Xu S, Ni L, Wang X (1999) Expression of autotaxin mRNA in human hepatocellular carcinoma. Chin Med J (Engl) 112: 330-332.
22. Cooper AB, Wu J, Lu D, Maluccio MA (2008) Is autotaxin (ENPP2) the link between hepatitis C and hepatocellular cancer? J Gastrointest Surg 11:1628-1634.
23. Wu JM, Xu Y, Skill NJ, Sheng H, Zhao Z, et al. (2010) Autotaxin expression and its connection with the TNF-alpha-NF-kappaB axis in human hepatocellular carcinoma. Mol Cancer 9: 71.
24. Scherer M, Schmitz G, Liebisch G (2009) High-throughput analysis of sphingosine 1-phosphate, sphinganine 1-phosphate, and lysophosphatidic acid in plasma samples by liquid chromatography-tandem mass spectrometry. Clin Chem;55:1218-1222.
25. Sisignano M, Angioni C, Ferreiros N, Schuh CD, Suo J, et al. (2013) Synthesis of lipid mediators during UVB-induced inflammatory hyperalgesia in rats and mice. PLoS One 8:e81228.
26. Nakamura K, Igarashi K, Ide K, Ohkawa R, Okubo S (2008) Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation. Clin Chim Acta 388:51-58. (Pubitemid 350266568)
27. Watanabe N, Ikeda H, Nakamura K, Ohkawa R, Kume Y, et al. (2007) Plasma lysophosphatidic acid level and serum autotaxin activity are increased in liver injury in rats in relation to its severity. Life Sci 81: 1009-1015. (Pubitemid 47386006)
28. Jansen S, Andries M, Vekemans K, Vanbilloen H, Verbruggen A (2009) Rapid clearance of the circulating metastatic factor autotaxin by the scavenger receptors of liver sinusoidal endothelial cells. Cancer Lett 284: 216-221.
29. Salous AK, Panchatcharam M, Sunkara M, Mueller P, Dong A (2013) Mechanism of rapid elimination of lysophosphatidic acid and related lipids from the circulation of mice. J Lipid Res 54:2775-2784.
30. Aoki J, Taira A, Takanezawa Y, Kishi Y, Hama K, et al. (2002) Serum lysophosphatidic acid is produced through diverse phospholipase pathways. J Biol Chem 277:48737-48744. (Pubitemid 35470839)
31. García-Pagán JC, Gracia-Sancho J, Bosch J (2012) Functional aspects on the pathophysiology of portal hypertension in cirrhosis. J Hepatol 57:458-461.
32. Ciećko-Michalska I, Szczepanek M, Słowik A, Mach T (2012) Pathogenesis of hepatic encephalopathy. Gastroenterol Res Pract 2012:642108.
33. Mazzocca A, Dituri F, Lupo L, Quaranta M, Antonaci S, et al. (2011)Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts. Hepatology 54:920-930.
34. Kondo M, Ishizawa T, Enooku K, Tokuhara Y, Ohkawa R, et al. (2014) Increased serum autotaxin levels in hepatocellular carcinoma patients were caused by background liver fibrosis but not by carcinoma. Clin Chim Acta 433:128-134.